PD-1 is expressed by activated T lymphocytes and is a crucial immune checkpoint receptor that mediates immunosuppression upon binding to its ligand PD-1 ligand-1 (PD-L1) expressed by tumor cells. This evidence concerns the gene PDCD1 and neoplasm.